Open AccessThis article is
- freely available
Gammaretroviral Vectors: Biology, Technology and Application
Department of Experimental Hematology, Hannover Medical School, OE6960-HBZ, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany
* Authors to whom correspondence should be addressed.
Received: 8 March 2011; in revised form: 3 May 2011 / Accepted: 9 May 2011 / Published: 3 June 2011
Abstract: Retroviruses are evolutionary optimized gene carriers that have naturally adapted to their hosts to efficiently deliver their nucleic acids into the target cell chromatin, thereby overcoming natural cellular barriers. Here we will review—starting with a deeper look into retroviral biology—how Murine Leukemia Virus (MLV), a simple gammaretrovirus, can be converted into an efficient vehicle of genetic therapeutics. Furthermore, we will describe how more rational vector backbones can be designed and how these so-called self-inactivating vectors can be pseudotyped and produced. Finally, we will provide an overview on existing clinical trials and how biosafety can be improved.
Keywords: Murine Leukemia Virus; gammaretroviral; split packaging design; SIN vector
Citations to this Article
Cite This Article
MDPI and ACS Style
Maetzig, T.; Galla, M.; Baum, C.; Schambach, A. Gammaretroviral Vectors: Biology, Technology and Application. Viruses 2011, 3, 677-713.
Maetzig T, Galla M, Baum C, Schambach A. Gammaretroviral Vectors: Biology, Technology and Application. Viruses. 2011; 3(6):677-713.
Maetzig, Tobias; Galla, Melanie; Baum, Christopher; Schambach, Axel. 2011. "Gammaretroviral Vectors: Biology, Technology and Application." Viruses 3, no. 6: 677-713.